Ninety Days to Trust: An Account Handler’s Playbook for a New Pharmaceutical Client

Winning a new pharmaceutical client is a commercial milestone, but it is not yet a partnership. For UK account handlers, the first 90 days are a handover period in which expectations are set, working habits are formed and reputations are made. The temptation is to demonstrate momentum through visible activity. The more durable approach is to demonstrate control through listening, governance and a clear operating rhythm.

In 2026, UK account teams are working across hybrid agency models, global brand structures and increasingly complex review routes. A new client may arrive with a global agency of record, a UK affiliate team, a medical affairs lead and a procurement function that all define success differently. The account handler’s task is not to resolve every ambiguity in week one. It is to surface the ambiguities early, agree how they will be handled and build enough trust for the work to move without avoidable friction.

Before kickoff: read the file and the room

Pre-kickoff research is not a luxury. It is the difference between a confident first meeting and a reactive one. Before the formal start, the account team should read the contract, statement of work, tender documents and any available brand or medical plans. Look for assumptions rather than answers: what has been promised, by whom and on what timeline? If a previous agency was involved, ask whether a structured handover is possible, while recognising that the client may not be able to share everything.

It is equally important to understand the client’s internal geography. Is the UK affiliate adapting global materials or creating local ones? Who owns medical and regulatory approval? Which decisions sit with the UK team and which require regional or global sign-off? For UK work, the ABPI Code and MHRA requirements will shape review routes, but the practical question is who applies them day to day and where the audit trail sits. A short pre-kickoff question log is more useful than a long assumptions document.

Set boundaries before the first deadline

Boundaries are often discussed only when something has gone wrong. A better approach is to agree them while everyone is still enthusiastic. The account handler should propose a one-page working charter covering meeting cadence, response times, approval routes, version control, escalation contacts and holiday cover. This is not bureaucracy for its own sake. It protects quality and reduces the risk of informal requests bypassing formal review.

The charter should also address scope. New clients often test the edges of a statement of work with small requests that seem unreasonable to refuse. A neutral phrase helps: ‘We can look at that; let me confirm whether it sits inside the agreed scope or needs a change note.’ This keeps the relationship constructive while protecting the team from unplanned work. In UK teams, where annual leave and client deadlines can collide, agreed cover arrangements are particularly valuable.

Map stakeholders beyond the org chart

An org chart shows reporting lines; a stakeholder map shows how decisions actually happen. Early in the engagement, identify the formal decision-makers, the influential reviewers, the gatekeepers and the people who will be asked for an informal opinion before a document is approved. Include medical, regulatory, market access, brand, procurement and, where relevant, patient affairs. For UK work, also check whether devolved health systems or local NHS structures affect the materials or the audience.

A simple map with four columns is enough: name, role, influence over the work and preferred way of working. Validate it with the client rather than treating it as an internal guess. Ask who needs to see early drafts and who prefers to review only near-final versions. Bring the compliance reviewer into the conversation early. Medical and regulatory review should not be treated as a late-stage hurdle; it is part of the route to a credible deliverable.

A phased first 90 days

The first 30 days should be about listening, auditing and confirming. The team should establish the charter, complete the stakeholder map, confirm the approval route and identify one or two modest early wins that do not compromise review. The next 30 days should test the operating model through a real deliverable cycle. This is where assumptions about review time, version control and client availability are either validated or revised.

By days 61 to 90, the account handler should be able to hold a formal check-in against agreed measures: did we meet the cadence, were approvals predictable, where did delays occur and what should change? The aim is not to declare victory but to document lessons and agree the next quarter’s priorities. A short review note shared with the client can be remarkably effective in building a culture of joint improvement.

Common early missteps

Overpromising is the most common error. Enthusiasm in a kickoff meeting can easily become a delivery commitment that the review process cannot support. Bypassing medical or regulatory review is another; it creates short-term speed and long-term risk. Assuming silence means approval is equally dangerous. So is confusing global materials with UK-ready materials, or treating compliance as an obstacle rather than a design parameter.

Other missteps include failing to document decisions, allowing small scope changes to accumulate without visibility and ignoring procurement’s view of value. Account handlers should also resist the urge to shield the client from every internal issue. Early transparency about capacity, review pressure or dependencies is more professional than a late apology.

A working checklist for the first 90 days

• Confirm scope, assumptions and change-control route.
• Read the contract, brand plan and available medical materials.
• Draft and agree a one-page working charter.
• Build and validate a stakeholder map.
• Confirm the UK review and approval route, including medical and regulatory roles.
• Agree meeting cadence, response times and holiday cover.
• Keep a risk and decision log from week one.
• Identify early wins that do not bypass review.
• Hold a 90-day review and document what will change.

The first 90 days are not a sprint to prove that the agency can do everything. They are a structured opportunity to prove that the account team can listen, organise and manage the relationship. In UK MedComms, where scientific accuracy and compliance are inseparable from commercial success, that early discipline is what turns a new client into a lasting partnership.